ALBERTO BARRIENTOS GUZMÁN-rekin lankidetzan egindako argitalpenak (8)

2012

  1. Everolimus as primary immunosuppression in kidney transplantation: Experience in conversion from calcineurin inhibitors

    Transplantation, Vol. 93, Núm. 4, pp. 398-405

  2. Limited-sampling strategy for mycophenolic acid in renal transplant recipients reciving enteric-coated mycophenolate sodium and tacrolimus

    Therapeutic Drug Monitoring, Vol. 34, Núm. 3, pp. 298-305

  3. Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation

    Transplantation Proceedings

  4. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients

    Nephrology Dialysis Transplantation, Vol. 27, Núm. 11, pp. 4227-4235

2002

  1. Study of nonimmunological factors that could be contributed to development of acute vascular rejection

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 360

2001

  1. Does renal mass exert an independent effect on the determinants of antigen-dependent injury?

    Transplantation, Vol. 71, Núm. 3, pp. 381-386

2000

  1. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: Mycophenolate versus azathioprine

    Transplantation, Vol. 69, Núm. 3, pp. 436-439

1998

  1. Effect of antithymocyte globulin induction treatment on renal transplant outcome

    Transplantation Proceedings